John C Seed
Medical Practice in Princeton, NJ
License number
New Jersey 25MA02052800
Issued Date
Jul 14, 1965
Expiration Date
Jun 30, 2009
Category
Medical Examiners
Type
Medical Doctor
Address
Address
Princeton, NJ
Personal information
See more information about John C Seed at radaris.comName
Address
Phone
33 Witherspoon St, Princeton, NJ 08542
33 Witherspoon Ct, Cranbury, NJ 08512
64 River Styx Rd, Hopatcong, NJ 07843
Professional information
Dr. John C Seed, Princeton NJ - MD (Doctor of Medicine)
Specialties:
Family Medicine
Address:
John C Seed MD
33 Witherspoon St, Princeton 08542
(609) 921-1720 (Phone)
33 Witherspoon St, Princeton 08542
(609) 921-1720 (Phone)
Certifications:
Family Practice, 1971
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
John C Seed MD
33 Witherspoon St, Princeton 08542
University Medical Center of Princeton at Plainsboro
1 Plainsboro Rd, Plainsboro 08536
33 Witherspoon St, Princeton 08542
University Medical Center of Princeton at Plainsboro
1 Plainsboro Rd, Plainsboro 08536
Education:
Medical School
Harvard Medical School
Graduated: 1945
Massachusetts General Hospital
Harvard Medical School
Graduated: 1945
Massachusetts General Hospital
Methods And Compositions For The Rapid And Enduring Relief Of Inadequate Myocardial Function
US Patent:
6159993, Dec 12, 2000
Filed:
Nov 24, 1998
Appl. No.:
9/198874
Inventors:
Brian Seed - Boston MA
John C. Seed - Princeton NJ
John C. Seed - Princeton NJ
Assignee:
Heart Care Partners - Princeton NJ
International Classification:
A61K 3120, A61K 3104
US Classification:
514356
Abstract:
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse cardiovascular events, or treating symptoms of inadequate myocardial function in a mammal involving administering to the mammal (a) a compound that includes eicosapentaeneoic acid or docosahexaeneoic acid and (b) a cholesterol-lowering therapeutic, combined with dietary restrictions (resulting in aggressive loading of marine lipids), whereby a serum LDL concentration of less than 75 mg/dl (and preferably less than 55 mg/dl) is achieved. One particular method involves administering to the mammal a combination that includes (a) a compound that includes an eicosapentaeneoic or docosahexaeneoic acid (for example, a marine lipid) and (b) a cholesterol synthesis or transfer inhibitor, and which may also optionally include aspirin and/or niacin. The methods and compositions of the invention may also further include a bile acid sequestrant and/or buspirone. Also disclosed are methods for treating heart disease that involve administration of buspirone.
Methods And Compositions For The Rapid And Enduring Relief Of Inadequate Myocardial Function
US Patent:
5861399, Jan 19, 1999
Filed:
Jul 17, 1996
Appl. No.:
8/680684
Inventors:
Brian Seed - Boston MA
John C. Seed - Princeton NJ
John C. Seed - Princeton NJ
Assignee:
Heart Care Partners - Princeton NJ
International Classification:
A61K 31495, A61K 3150, A61K 3144, A61K 3140
US Classification:
514252
Abstract:
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse cardiovascular events, or treating symptoms of inadequate myocardial function in a mammal involving administering to the mammal (a) a compound that includes eicosapentaeneoic acid or docosahexaeneoic acid and (b) a cholesterol-lowering therapeutic, combined with dietary restrictions (resulting in aggressive loading of marine lipids), whereby a serum LDL concentration of less than 75 mg/dl (and preferably less than 55 mg/dl) is achieved. One particular method involves administering to the mammal a combination that includes (a) a compound that includes an eicosapentaeneoic or docosahexaeneoic acid (for example, a marine lipid) and (b) a cholesterol synthesis or transfer inhibitor, and which may also optionally include aspirin and/or niacin. The methods and compositions of the invention may also further include a bile acid sequestrant and/or buspirone. Also disclosed are methods for treating heart disease that involve administration of buspirone.
Methods And Compositions For The Rapid And Enduring Relief Of Inadequate Myocardial Function
US Patent:
7109206, Sep 19, 2006
Filed:
Dec 12, 2000
Appl. No.:
09/735024
Inventors:
Brian Seed - Boston MA, US
John C. Seed - Princeton NJ, US
John C. Seed - Princeton NJ, US
Assignee:
Heart Care Partners - Princeton NJ
International Classification:
A61K 31/505, A61K 31/44, A61K 31/40, A61K 31/35, A61K 31/21
US Classification:
514275, 514356, 514419, 514460, 514510, 424523
Abstract:
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse cardiovascular events, or treating symptoms of inadequate myocardial function in a mammal involving administering to the mammal (a) a compound that includes eicosapentaeneoic acid or docosahexaeneoic acid and (b) a cholesterol-lowering therapeutic, combined with dietary restrictions (resulting in aggressive loading of marine lipids), whereby a serum LDL concentration of less than 75 mg/dl (and preferably less than 55 mg/dl) is achieved. One particular method involves administering to the mammal a combination that includes (a) a compound that includes an eicosapentaeneoic or docosahexaeneoic acid (for example, a marine lipid) and (b) a cholesterol synthesis or transfer inhibitor, and which may also optionally include aspirin and/or niacin. The methods and compositions of the invention may also further include a bile acid sequestrant and/or buspirone. Also disclosed are methods for treating heart disease that involve administration of buspirone.
Method Of Assisting Weight Loss
US Patent:
4895845, Jan 23, 1990
Filed:
Sep 15, 1986
Appl. No.:
6/907837
Inventors:
John C. Seed - Princeton NJ
International Classification:
A61K 3150, A61K 31495, A61K 3144, A61K 31135
US Classification:
514252
Abstract:
A method of assisting weight loss involving the combined administration of a rauwolfia alkaloid and at least one antidepressant, selected from the groups consisting of aminoazoles, phenoxyphenylpropylamines, and aminopropiophenones, in a daily regimen with the optional co-administration of one or more sympathomimetic anorexic agents. In a typical embodiment of this method, reserpine and trazodone are administered in a daily regimen with diethylpropion, fenfluramine or both diethylpropion and fenfluramine.
Combination Drug Therapy To Treat Obesity
US Patent:
2005014, Jun 30, 2005
Filed:
Nov 18, 2004
Appl. No.:
10/993496
Inventors:
John Seed - Princeton NJ, US
International Classification:
A61K031/66, A61K031/55, A61K031/5415, A61K031/473, A61K031/4439, A61K031/426, A61K031/407
US Classification:
514114000, 514225800, 514340000, 514411000, 514365000, 514297000, 514214030
Abstract:
Provided are methods of achieving desirable weight loss in an overweight or obese individual by administering at least one anticholinesterase agent and at least one antidepressant. The invention also provides for pharmaceutical compositions and kits for simultaneous delivery of at least one anticholinesterase agent and at least one antidepressant.
Compositions And Methods For Promoting Weight Loss
US Patent:
2009011, Apr 30, 2009
Filed:
Oct 25, 2007
Appl. No.:
11/924189
Inventors:
John C. Seed - Princeton NJ, US
Denise Johnson - Trenton NJ, US
Denise Johnson - Trenton NJ, US
International Classification:
A61K 36/68, A23L 1/236, A61P 3/04, A23L 1/36
US Classification:
424738, 426548, 426629
Abstract:
Compositions, which include psyllium and polyethylene glycol in a weight ratio of psyllium to polyethylene glycol of from about 1:3 to about 2:1, a gum, and one or more additional ingredients selected from the group consisting of water, salt, sweeteners, flavoring agents, and preservatives are presented.
Compositions And Methods For Promoting Weight Loss
US Patent:
2009023, Sep 24, 2009
Filed:
May 29, 2009
Appl. No.:
12/474745
Inventors:
John C. Seed - Princeton NJ, US
International Classification:
A61K 36/68
US Classification:
424738
Abstract:
Compositions, which include psyllium and polyethylene glycol in a weight ratio of psyllium to polyethylene glycol of from about 1:3 to about 2:1, a gum, and one or more additional ingredients selected from the group consisting of water, salt, sweeteners, flavoring agents, and preservatives are presented.
Use Of Relaxin As An Analgesic And Palliative For Intractable Pain
US Patent:
5656592, Aug 12, 1997
Filed:
Sep 29, 1993
Appl. No.:
8/128912
Inventors:
Brian Seed - Boston MA
John C. Seed - Princeton NJ
John C. Seed - Princeton NJ
International Classification:
C07K 1464, A61K 3822
US Classification:
514 12
Abstract:
Disclosed is a method of reducing pain in a mammal involving administration of relaxin to the mammal.